Case Report

Metastatic Breast Carcinoma Presenting with Profound Hypocalcemia

Authors: Timothy Cooksley, MBChB, Moulinath Banerjee, MD, Naveed Younis, MD

Abstract

Hypocalcemia is a rare complication of malignancy. We present the case of a 30-year-old lady presenting with a grand mal seizure due to profound hypocalcemia. She was subsequently found to be hypoparathyroid and was diagnosed with metastatic breast carcinoma. Treatment with goserelin and exemestane produced a significant reduction in her tumor load and a correction of her hypocalcemia, which was initially refractory to treatment. We believe this to be the first case of metastatic breast carcinoma actually presenting with hypocalcemia and feel that clinicians should be aware of this rare complication.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Tandon PK, Rizvi AA. Hypocalcemia and parathyroid function in metastatic prostate cancer. Endocr Pract 2005;11:254–258.
 
2. Smallridge RC, Wray HL, Schaaf M. Hypocalcaemia with osteoblastic metastases in a patient with prostate cancer. Am J Med 1981;71:184–188.
 
3. Berruti A, Sperone P, Fasolis G, et al. Pamidronate administration improves the secondary hyperparathyroidism due to “Bone Hunger Syndrome” in a patient with osteoblastic metastases from prostate cancer. Prostate 1997;33:252–255.
 
4. Lim SC, Tan CE, Aw TC, et al. A man with osteoblastic metastases and hypocalcaemia. Singapore Med J 2000;41:74–76.
 
5. Grieve RJ, Dixon PF, Roberts H, et al. Hypocalcaemia—an unusual complication of successful chemotherapy for metastatic breast cancer. Clin Oncol 1983;9:337–342.
 
6. Hermus A, Beex L, van Liessum P, et al. Hypocalcemia due to osteoblastic metastases and diminished parathyroid reserve in a patient with advanced breast cancer. Klin Wochenschr 1988;66:643–646.
 
7. Dawson SJ, Murray RM, Rischin D. Hypocalcemia associated with bone metastases in a patient with salivary gland carcinoma. Nat Clin Pract Oncol 2006;3:104–107.
 
8. Riancho JA, Arjona R, Valle R, et al. The clinical spectrum of hypocalcaemia associated with bone metastases. J Intern Med 1989;226:449–452.
 
9. Bhattacharyya A, Buckler HM, New JP. Hungry Bone Syndrome–revisited. J R Coll Physicians Edinb 2002;32:83–86.
 
10. Harley HA, Mason R, Phillips PJ. Profound hypocalcaemia associated with oestrogen treatment of carcinoma of the prostate. Med J Aust 1983;2:41–42.
 
11. Horwitz CA, Myers WP, Foote FW Jr. Secondary malignant tumors of the parathyroid glands: reports of two cases with associated hypoparathyroidism. Am J Med 1972;52:797–808.
 
12. Bergkamp FJ, van Berkel AM, van der Linden PW, et al. Unexpected prolonged extreme hypocalcaemia and an inadequate PTH response in a patient with metastatic breast carcinoma. Neth J Med 2003;61:371–375.
 
13. Watanabe T, Adachi I, Kimura S, et al. A case of advanced breast cancer associated with hypocalcemia. Jpn J Clin Oncol 1983;61:441–448.